Literature DB >> 5478208

Marchiafava-Bignami's disease. Report of the first case in an Asian.

T Ishizaki, H Chitanondh, U Laksanavicharn.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5478208     DOI： 10.1007/BF00687358

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  3 in total

1.  [Marchiafava's disease].

Authors:  F SEITELBERGER; P BERNER
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1955

2.  Central demyelination of the corpus callosum (Marchiafava-Bignami disease) with report of a second case in Great Britain.

Authors:  R IRONSIDE; F D BOSANQUET; W H McMENEMEY
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

3.  Marchiafava-Bignami's disease; report of a second case in native-born Americans.

Authors:  W RIESE; G L JONES; E BEAMER-MAXWELL; H E DAVIS
Journal:  J Neuropathol Exp Neurol       Date:  1954-07       Impact factor: 3.685
  3 in total
  4 in total

1.  Hemispheric disconnection syndrome with a "crossed avoiding" reaction in a case of Marchiafava-Bignami disease.

Authors:  B Lechevalier; J C Andersson; P Morin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-05       Impact factor: 10.154

2.  Acute Marchiafava-Bignami disease presenting as reversible dementia in a chronic alcoholic.

Authors:  Vineet Sehgal; Praveen Kesav; M Modi; Chirag K Ahuja
Journal:  BMJ Case Rep       Date:  2013-02-15

3.  Primary necrosis of corpus callosum with dystrophic astrogliosis and Rosenthal-like fiber formation. The first Chinese case of Marchiafava-Bignami's disease (MBD).

Authors:  K C Ma; K J Chen
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

4.  Marchiafava-Bignami disease, striatal degeneration, and other neurological complications of chronic alcoholism in a Japanese.

Authors:  Y Sato; T Tabira; J Tateishi
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.